Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis. - Wikidata - awgldk - TriplyDB

Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis.

Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis.

http://www.wikidata.org/entity/Q33371890

about

Interferon for Hepatitis C Virus in Hemodialysis--an Individual Patient Meta-analysis of Factors Associated with Sustained Virological Response Direct-acting antivirals for the treatment of chronic hepatitis C in patients with chronic kidney disease Diagnosis, management, and treatment of hepatitis C: an update Treatment of hepatitis C in hemodialysis patients using pegylated interferon alpha-2a in Turkey.Pegylated interferon monotherapy for hepatitis C virus infection in patients on hemodialysis: A single center study Hepatitis C virus infection and dialysis: 2012 update.Hepatitis C and kidney transplantation Hepatitis C virus infection and the dialysis patient.Efficacy and safety of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.Treatment of chronic hepatitis C in hemodialysis patients.A meta-analysis that compares the use of either peginterferon-α2a or peginterferon-α2b plus ribavirin for HCV infection.Pegylated interferon monotherapy of chronic hepatitis C in dialysis patients: Meta-analysis of clinical trials.Hepatic disorders in chronic kidney disease.Treatment of hepatitis C virus infection in patients with end-stage renal disease.Pegylated Interferon Mono-Therapy of Chronic Hepatitis C in the Dialysis Population: Systematic Review and Meta-Analysis.Interferon treatment for patients with chronic hepatitis C complicated with chronic renal failure receiving hemodialysis.Kinetics of hepatitis C viral RNA and HCV-antigen during dialysis sessions: evidence for differential viral load reduction on dialysis.2011 Japanese Society for Dialysis Therapy guidelines for the treatment of hepatitis C virus infection in dialysis patients.Safety and efficacy of an escalating dose regimen of pegylated interferon alpha-2b in the treatment of haemodialysis patients with chronic hepatitis C.Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy.

P2860

Q27489433-53C2A650-8F98-4DD7-8AEB-28737ABA5676 Q28077263-E358914A-8EB7-4A8D-88FE-52FEF2EBA928 Q29619682-7FF9DC10-C8F1-4F3E-8375-23A5D5669FB4 Q33383646-42F36D6B-39FE-4188-B597-2B84038EE868 Q33434493-36F2661A-5822-4A24-84E7-65CEE10AA2E0 Q33710828-247441F4-13DD-4C46-ACF2-57879BE993D1 Q35094769-0F34CCE4-F78C-4372-80B9-7FBC6298D336 Q36952566-C4CF4B6F-5A0F-4C7A-A63F-209A211FA5E4 Q37174162-3D42A768-E831-48FA-9635-D348E1D91F74 Q37313163-B2165BFA-F54F-4056-8AB3-15D6727C8C01 Q37355366-9AFD15A6-CD39-4BDC-8B67-6D36C5043791 Q37718739-7EF37CE7-3411-427A-8E10-A65AB05B026D Q37729824-7D3E9AC2-545B-4156-AA34-C96C20BDA965 Q37831965-73A83212-9AB4-42CC-B751-99BA055E3D8D Q38551615-AC49A8E9-BD8B-4276-9222-9AD788FFDF07 Q39488889-E935FB24-26DA-4210-A798-0B137483A3D3 Q42978264-B28DFE95-C31F-4C06-8E47-E6DB4C64107C Q42982450-31A17181-A8BF-4539-94E8-9C7849FA529D Q42990995-CBE0EF47-CF8E-4707-A83B-27F0CEBEE49F Q50556069-F8DC4DD5-3F85-4E66-A4D5-D79A2F44AFDE

P2860

Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis.

http://www.wikidata.org/entity/Q33371890

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Pegylated-interferon alpha 2a ...... ents on chronic haemodialysis.

@ast

Pegylated-interferon alpha 2a ...... ents on chronic haemodialysis.

@en

type

label

Pegylated-interferon alpha 2a ...... ents on chronic haemodialysis.

@ast

Pegylated-interferon alpha 2a ...... ents on chronic haemodialysis.

@en

prefLabel

Pegylated-interferon alpha 2a ...... ents on chronic haemodialysis.

@ast

Pegylated-interferon alpha 2a ...... ents on chronic haemodialysis.

@en

P1433

Q33371890-E4B84416-6177-4041-9F73-12F3A170531A

P1476

Q33371890-0D614591-0167-4200-BB5C-5848B94C5466

P2093

Q33371890-44242A55-825E-413C-A690-64379F8F3203

Q33371890-7BE99F99-E0D0-48D5-ABD1-4282BEEDF4DB

Q33371890-90F1BB4B-ED12-420A-BBCA-F0001F232EBB

Q33371890-B4247E58-EFB2-43AB-9A28-BDDF41BAA600

Q33371890-B76B6680-A08E-4979-A2EA-6A42B83A52CE

Q33371890-EFE1B949-6767-466C-99AA-977A9B0FA254

P2860

Q33371890-01DE55A5-7220-47CA-86DF-DBF8EB30E7A2

Q33371890-0D12EC74-9001-4A23-9FC8-EC1676234B35

Q33371890-24370C8A-4B58-41F2-A51D-A9134B2C3A9F

Q33371890-2447841B-C211-475D-AEA4-7704828D2D06

Q33371890-371C9891-604B-4CE9-93F6-3A4D4BCD8F1A

Q33371890-46FFE8A3-FAEF-4821-AAE4-FA247ABC29D4

Q33371890-48BD198B-0A9C-4309-8EB2-BD30963CA8E2

Q33371890-4E65955F-20A4-4841-8E69-AA8379CB6419

Q33371890-59E2C247-2DA1-4AD6-BB0D-A7448D000FFD

Q33371890-62B60F74-58E6-43D4-ACAE-3B21F4F491AB

P304

Q33371890-7CF45BF4-9FC4-4CF4-9769-0518A7195C0C

P31

Q33371890-D22BBCD9-6017-452C-ACAE-C8B56AEDF290

P356

Q33371890-3C9149DB-4A10-4932-A88D-02464D7F2C76

P407

Q33371890-6D39BA1D-EBAB-4CF5-ACEE-DA047F65B49F

P433

Q33371890-7778EC92-C2A2-4F15-82D0-AE7AEB2A32DA

P478

Q33371890-C495BDF5-858B-4B85-934E-D6C3A7A4C9ED

P50

Q33371890-71F9B363-6A83-43A7-9A70-63174AE081F6

P577

Q33371890-51872372-B48E-46FF-9E98-F44025468C2B

P5875

Q33371890-22ABCA11-21DC-4C8C-912E-D2412B5F4720

P698

Q33371890-9FB23EB0-56B1-4B39-82CF-6B2AEDB9EA0E

P932

Q33371890-51255BE4-4AB0-4069-9EE7-3B005D4EBAA3

P356

WJG.V12.I26.4191

P1433

World Journal of Gastroenterology

P1476

Pegylated-interferon alpha 2a ...... ients on chronic haemodialysis

@en

P2093

Alina Popescu

http://www.w3.org/2001/XMLSchema#string

Camelia Totolici

http://www.w3.org/2001/XMLSchema#string

Corina Vernic

http://www.w3.org/2001/XMLSchema#string

Ioan Sporea

http://www.w3.org/2001/XMLSchema#string

Mirela Danila

http://www.w3.org/2001/XMLSchema#string

Ovidiu Golea

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C virus infections in dialysis centers in The Netherlands: a national survey by serological and molecular methods

Treatment of hepatitis C virus infection after renal transplantation: new insights.

Interferon-alpha-induced acute renal allograft rejection.

Hepatitis C infection and the patient with end-stage renal disease.

Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients.

Histopathological features of hepatitis C in renal transplant candidates [see comment]

Confirmation of nosocomial hepatitis C virus infection in a hemodialysis unit.

European study on epidemiology and the management of HCV in the haemodialysis population--Part 1: centre policy.

High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapy.

Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group.

P304

4191-4194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V12.I26.4191

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

298738127

http://www.w3.org/2001/XMLSchema#string

P698

16830372

http://www.w3.org/2001/XMLSchema#string

P932

4087371

http://www.w3.org/2001/XMLSchema#string